Asklepios Kliniken GmbH: Preliminary figures 2012
New medical services generate growth of organic revenue and operating result
In comparison to the previous year, the Asklepios Group has increased the number of patients by +14.7 per cent, reaching nearly two million. Thereby, their position as a leading private hospital group in Germany was once again confirmed.
Sales rose by +16.5 per cent (with 3.4 percentage points of this being organic) to 2.98 bn. Euro. For the first time, the new MediClin AG clinics had an all-year effect. The positive sales development was predominantly a result of patient growth. The operating result (EBITDAR) could be increased by +33.5 per cent to roughly 323 bn. Euro. Thus, the margin improved significantly to 10.8 per cent, and reflected the first successes of the integration of MediClin AG and the Asklepios Group through the establishment of regional structures.
Asklepios looks back on the fiscal year 2012 with satisfaction. The strategy of growth combined with good judgement has paid off for our concern group, says Stephan Leonhard, Vice Chairman of Corporate Management and CFO.